Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Plos One|December 29, 2012
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancerYann Neuzillet, Xavier Paoletti, Slah Ouerhani, et al.
European Urology|October 20, 2023
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 GuidelinesJ Alfred Witjes, Harman Max Bruins, Albert Carrión, et al.
World Journal of Urology|July 1, 2021
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survivalFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Science Translational Medicine|July 11, 2014
EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotypeSandra Rebouissou, Isabelle Bernard-Pierrot, Aurélien de Reyniès, et al.
Nature Communications|January 18, 2019
Recurrent activating mutations of PPARγ associated with luminal bladder tumorsNatacha Rochel, Clémentine Krucker, Laure Coutos-Thévenot, et al.
Nature Communications|October 4, 2024
The genomic and transcriptomic landscape of metastastic urothelial cancerYohann Loriot, Maud Kamal, Laurene Syx, et al.
Clinical Genitourinary Cancer|December 29, 2019
Neuroendocrine Carcinoma of the Urinary Bladder: A Large, Retrospective Study From the French Genito-Urinary Tumor GroupMarine Sroussi, Reza Elaidi, Aude Fléchon, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical CystectomyErik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
Pageof 15